Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clear Nose VC is a branded generic nutritional supplement developed by KEN Pharmaceuticals, typically formulated as a chewable tablet. It contains a combination of **ascorbic acid (Vitamin C)** and **zinc**, which are essential nutrients known for their roles in supporting the immune system, promoting wound healing, and providing antioxidant protection. The product is marketed for the prevention and treatment of Vitamin C and zinc deficiencies, and as an adjunct therapy for the common cold and other respiratory infections. While the 'Clear Nose' brand is also associated with nasal decongestant products (containing xylometazoline), the 'VC' variant specifically denotes the Vitamin C-containing oral formulation, often launched as an immunity-boosting product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbic acid + zinc (Ken Pharmaceuticals).